TCL Archive In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure July 5, 1991
TCL Archive Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations June 28, 2013
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013